Contact
 

AVAC Statement on Results of New PrEP Trials

AVAC says results of new PrEP trials provide clear evidence that antiretroviral  drugs for prevention can help end the AIDS epidemic; calls for quick action  to move landmark HIV prevention results toward lifesaving programs.  Read the full statement below. 

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account